Table 4.
Oncological outcomes before and after propensity score-matching
| Overall cohort | Matched cohort | ||||
|---|---|---|---|---|---|
| MIS | Open | MIS | Open | ||
| (n = 33) | (n = 36) | (n = 23) | (n = 23) | ||
| Recurrence | 19 (57.6) | 19 (52.8) | 14 (60.9) | 12 (52.2) | |
| Multiple | 4 (12.1) | 5 (13.9) | 2 (8.7) | 2 (8.7) | |
| Distant* | 17 (51.5) | 15 (41.7) | 12 (52.2) | 7 (30.4) | |
| Lung* | 8 (24.2) | 7 (19.4) | 5 (21.7) | 4 (17.4) | |
| Liver* | 5 (15.2) | 3 (8.3) | 3 (13.0) | 3 (13.0) | |
| Distant lymph node* | 6 (18.2) | 7 (19.4) | 5 (21.7) | 4 (17.4) | |
| Peritoneal* | 1 (3.0) | 3 (8.3) | 1 (4.3) | 0 | |
| Bone* | 0 | 1 (2.8) | 0 | 0 | |
| Spleen* | 0 | 1 (2.8) | 0 | 0 | |
| Local* | 2 (6.1) | 6 (16.7) | 2 (8.7) | 5 (21.7) | |
Values in parentheses are percentages, unless indicated otherwise
MIS Minimally invasive surgery
*Contains duplicates